Issuer Data Corner
LAVIPHARM S.A.
Traded on ATHEX
Issuer Information
Activity | Manufacture and import of pharmaceuticals and veterinary products and related research and development activities. |
---|---|
Year of Establishment | 1975 |
Voting Rights (>=5%) | LAVIPHARM GROUP HOLDING SA (61.85%) |
Company Staff Number | - |
Group Staff | 307 |
Investor Relations Officer | Mr Baloumis Vasilis |
Date of Listing | 1995.11.08 |
Sector / Sub-sector | Health Care / Pharmaceuticals |
Participation in Indices | ATHEX_ESG, DOM, FTSEA, FTSEM, GD, SAGD, TR_FTSEM |
Market Segment | MAIN MARKET (2011.10.10) |
Market Capitalization | 132,422,464.0500 |
Contact Information
Address | AG. MARINAS 12 Postal Code:19002 PAIANIA |
---|---|
Phone Number | (210)-6691000 |
Telefax | (210)-6645386 |
communications@lavipharm.com | |
Website | http://www.lavipharm.com |
Contact Person | Mrs. Fragioudaki Catherine |
Board of Directors
Full Name (Title) | |
---|---|
TANES G MINAS (CHAIRMAN/NON EXECUTIVE MEMBER) | |
LAVIDA VENETSIANA-LOUKIA (VICE PRESIDENT/EXECUTIVE MEMBER) | |
LAVIDAS A TELEMAQUE JEAN (CEO/EXECUTIVE MEMBER) | |
GIANNOULEAS S PANAGIOTIS (DEPUTY MANAGING DIRECTOR/EXECUTIVE MEMBER) | |
DIAMANTOPOULOS P CHRISTOS (NON EXECUTIVE MEMBER) | |
EFRAIMOGLOY-KOYNENAKI K SOFIA (INDEPENDENT NON EXECUTIVE MEMBER) | |
CHRISTOPOULOS P DIMITRIOS (INDEPENDENT NON EXECUTIVE MEMBER) | |
KEFALA D VASILIKI (INDEPENDENT NON EXECUTIVE MEMBER) |